A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE III TRIAL OF EVEROLIMUS IN PATIENTS WITH ADVANCED PANCREATIC NEUROENDOCRINE TUMORS (PNET) (RADIANT-3)

被引：0

作者：

Yao, J. C. ^{[1
]}

Shah, M. H. ^{[2
]}

Ito, T. ^{[3
]}

Lombard-Bohas, C. ^{[4
]}

Wolin, E. M. ^{[5
]}

Van Cutsem, E. ^{[6
]}

Sachs, C.

Hoosen, S. ^{[7
]}

Lincy, J. ^{[7
]}

Hobday, T. ^{[8
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA

[3] Kyushu Univ, Grad Sch Med Sci, Fukuoka 812, Japan

[4] Hosp Civils Lyon, Hop E Herriot, Lyon, France

[5] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA

[6] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium

[7] Novartis Oncol, Florham Pk, NJ USA

[8] Mayo Clin, Rochester, MN USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：4 / 5

页数：2